Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis

Actinium-225 is an alpha-particle emitter under investigation for use in radiopharmaceutical therapy. To address limited supply, accelerator-produced 225Ac has been recently made available. Accelerator-produced 2...

Source: EJNMMI Physics - August 18, 2021 Category: Radiology Authors: George Sgouros, Bin He, Nitya Ray, Dale L. Ludwig and Eric C. Frey Tags: Original research Source Type: research